![]() |
市場調査レポート
商品コード
921873
世界の自家細胞治療薬市場:成長、動向、および予測(2020年~2025年)Autologous Cell Therapy Market - Growth, Trends, and Forecasts (2020 - 2025) |
世界の自家細胞治療薬市場:成長、動向、および予測(2020年~2025年) |
出版日: 2020年06月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 112 Pages
納期: 2-3営業日
|
世界の自家細胞治療薬市場は、予測期間中に15.9%のCAGRで成長する見通しです。同市場の成長に寄与している主な要因は、自己免疫疾患、癌、血液障害などの慢性疾患の発生率の上昇、および慢性疾患に苦しむ人口の増加です。自家細胞治療市場を次のレベルに引き上げる上で重要な役割を果たしている要因の一つは、新しい用途のための進行中の薬剤開発であり、同市場の成長をさらに推進すると予測されています。
当レポートは世界の自家細胞治療薬市場について調査しており、市場機会や動向、成長および阻害要因、療法・用途・素材・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。
The Autologous Cell Therapy market studied was anticipated to grow with a CAGR of 15.9%, during the forecast period. The major factors attributing to the growth of the autologous cell therapy market are the rising incidence of chronic diseases such as autoimmune diseases, cancer, blood disorder, and others. A rise in the population suffering from chronic diseases is also propelling the demand for market growth. In 2018, as per the AARDA (American Autoimmune Related Diseases Association) statistics, around 50 million Americans have an autoimmune disease, and this number is expected to rise in the future. As per the CDC (Centers for Disease Control and Prevention) estimates Sickel Cell Disease (SCD) affects around 100,000 Americans annually. And there are few more factors which are playing crucial roles in taking the autologous cell therapy market to the next level, among them one is on-going drug developments for new applications which are expected to further propel the growth of the autologous cell therapy market.
Bone Marrow Segment is Expected to Hold the Largest Market Share in the Autologous Cell Therapy Market
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall autologous cell therapy market, throughout the forecast period. This is owing to factors such as the rising incidence of chronic diseases such as cancer, blood disorder, autoimmune diseases, and other diseases and the availability of advanced healthcare infrastructure among the major factors. In North America region, the United States holds the largest market share owing to the factors such as increasing number of population suffering from cancer and other chronic diseases, along with the rising geriatric population and developments related to stem cell therapy and rising demand for biotechnological practices in the country, is anticipated to further drive the demand in this region.
The autologous cell therapy market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Vericel Corporation, Pharmicell Co., Inc., Holostem Terapie Avanzate S.r.l., Lineage Cell Therapeutics, Inc., and Opexa Therapeutics.